Notice: This company has been marked as potentially delisted and may not be actively trading. RVL Pharmaceuticals (RVLP) News Today Add Compare Share Share Headlines Stock Analysis All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street TipRanks The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 December 2021 Time Period Unravel Biosciences Receives FDA Orphan Drug Designation for Vorinostat (RVL-001) as a Treatment for Rett SyndromeMay 28, 2024 | tmcnet.comRaval ICS Ltd.May 17, 2024 | wsj.comRVLPQ RVL Pharmaceuticals plcMarch 2, 2024 | seekingalpha.comRVL Pharmaceuticals PLC RVLPQJanuary 11, 2024 | morningstar.comRVL Pharmaceuticals Shares Plummet 50% as Subsidiaries File For BankruptcyOctober 13, 2023 | marketwatch.comSpecialty Pharma Firm RVL Pharmaceuticals Subsidiaries File for BankruptcyOctober 12, 2023 | benzinga.comRVL Subsidiaries To Effectuate Change Of Control; RVLP Ordinary Shares Expected To Be CancelledOctober 12, 2023 | markets.businessinsider.comRVL Pharmaceuticals Subsidiaries File for BankruptcyOctober 12, 2023 | finance.yahoo.comWhy Is RVL Pharmaceuticals (RVLP) Stock Up 28% Today?October 6, 2023 | investorplace.comUnmasking the Value Trap: A Deep Dive into RVL Pharmaceuticals PLCAugust 23, 2023 | finance.yahoo.comRVL Pharmaceuticals plc to Present at the H.C. Wainwright 25th Annual Global Investment ConferenceAugust 23, 2023 | finance.yahoo.comRVL Pharmaceuticals (RVLP) Gets a Buy from H.C. WainwrightAugust 21, 2023 | markets.businessinsider.comCrude Oil Falls Sharply; RVL Pharmaceuticals Shares PlummetAugust 16, 2023 | benzinga.comRVLP: Second Quarter ResultsAugust 16, 2023 | msn.comRVL Pharmaceuticals Shares Hit New Lows After Stock Sale >RVLPAugust 16, 2023 | marketwatch.comRVL Pharmaceuticals shares fall after pricing $5M stock offeringAugust 16, 2023 | msn.comDowngrade: Here's How Analysts See RVL Pharmaceuticals plc (NASDAQ:RVLP) Performing In The Near TermAugust 16, 2023 | finance.yahoo.comRVL Pharmaceuticals plc Announces $5 Million Registered Direct Offering Priced At-the-Market under Nasdaq RulesAugust 16, 2023 | finance.yahoo.comQ2 2023 RVL Pharmaceuticals PLC Earnings CallAugust 15, 2023 | finance.yahoo.comRVLP: Revenue Dip Prompts Spending ReversalAugust 14, 2023 | msn.comRVL Pharmaceuticals plc Reports Second Quarter 2023 Financial Results; Provides Update on Strategic Business ReviewAugust 14, 2023 | finance.yahoo.comInsiders Re-Evaluate Their US$1.6m Stock Purchase As RVL Pharmaceuticals Falls To US$43mJuly 20, 2023 | finance.yahoo.comRVL Pharma (NASDAQ:RVLP) Rises on Mulling A Strategic TransactionJuly 5, 2023 | msn.comRVL Pharmaceuticals shares are trading higher after the company said it has been considering certain strategic alternatives.July 5, 2023 | benzinga.comRVL Pharmaceuticals plc Announces Result of Proposal to Approve a Waiver of Offer Obligations under Rule 9 of the Irish Takeover Rules at Annual General MeetingJune 15, 2023 | finance.yahoo.comShareholders in RVL Pharmaceuticals (NASDAQ:RVLP) are in the red if they invested three years agoJune 2, 2023 | finance.yahoo.comTime To Worry? Analysts Just Downgraded Their RVL Pharmaceuticals plc (NASDAQ:RVLP) OutlookMay 13, 2023 | finance.yahoo.comRVLP: First Quarter ResultsMay 12, 2023 | finance.yahoo.comRVL Pharmaceuticals: Q1 Earnings InsightsMay 12, 2023 | msn.comQ1 2023 RVL Pharmaceuticals PLC Earnings CallMay 12, 2023 | finance.yahoo.comEarnings Preview: RVL PharmaceuticalsMay 10, 2023 | msn.comRVLP: Selected for NewBeauty AwardMay 1, 2023 | finance.yahoo.comBarclays Sticks to Their Buy Rating for RVL Pharmaceuticals (RVLP)May 1, 2023 | markets.businessinsider.comRVL Pharmaceuticals Stock (NASDAQ:RVLP), DividendsApril 26, 2023 | benzinga.comInvestors Aren't Entirely Convinced By RVL Pharmaceuticals plc's (NASDAQ:RVLP) RevenuesApril 17, 2023 | finance.yahoo.comRVL Pharmaceuticals plc (NASDAQ:RVLP) Short Interest UpdateRVL Pharmaceuticals plc (NASDAQ:RVLP - Get Rating) saw a large decrease in short interest during the month of March. As of March 31st, there was short interest totalling 113,600 shares, a decrease of 18.9% from the March 15th total of 140,000 shares. Based on an average daily trading volume, of 51,600 shares, the days-to-cover ratio is presently 2.2 days. Approximately 0.2% of the company's stock are sold short.April 16, 2023 | marketbeat.comRVL Pharmaceuticals plcApril 9, 2023 | thestreet.comRVL Pharmaceuticals Announces that Upneeq(R) Wins "Best Eye Drop for Drooping Lids" NewBeauty in 13th Annual Beauty AwardsApril 4, 2023 | marketwatch.comRVL Pharmaceuticals Announces that Upneeq® Wins “Best Eye Drop for Drooping Lids” NewBeauty in 13th Annual Beauty AwardsApril 3, 2023 | finance.yahoo.comShould You Hold RVL Pharmaceuticals plc (RVLP) for a Potential Upside?March 24, 2023 | finance.yahoo.comFY2023 EPS Estimates for RVL Pharmaceuticals plc Increased by Analyst (NASDAQ:RVLP)RVL Pharmaceuticals plc (NASDAQ:RVLP - Get Rating) - Cantor Fitzgerald increased their FY2023 EPS estimates for RVL Pharmaceuticals in a research note issued to investors on Tuesday, March 21st. Cantor Fitzgerald analyst L. Chen now expects that the company will post earnings of ($0.30) per shareMarch 23, 2023 | marketbeat.comRVL Pharmaceuticals plc (NASDAQ:RVLP) Q4 2022 Earnings Call TranscriptMarch 22, 2023 | finance.yahoo.comRVL Pharmaceuticals plc - Ordinary Shares's Return On Capital Employed InsightsMarch 21, 2023 | msn.comH.C. Wainwright Sticks to Their Buy Rating for RVL Pharmaceuticals (RVLP)March 21, 2023 | markets.businessinsider.comRVLP: Telemedicine & E-commerce to Drive 2H:23 GrowthMarch 21, 2023 | finance.yahoo.comQ4 2022 RVL Pharmaceuticals PLC Earnings CallMarch 21, 2023 | finance.yahoo.comEarnings Outlook For RVL Pharmaceuticals plc - Ordinary SharesMarch 17, 2023 | benzinga.comWorth Venture Partners LLC Takes Position in RVL Pharmaceuticals plc (NASDAQ:RVLP)Worth Venture Partners LLC acquired a new stake in shares of RVL Pharmaceuticals plc (NASDAQ:RVLP - Get Rating) during the third quarter, according to its most recent disclosure with the SEC. The fund acquired 185,647 shares of the company's stock, valued at approximately $390,000. Worth Venture PaFebruary 24, 2023 | marketbeat.comPrivate equity firms account for 39% of RVL Pharmaceuticals plc's (NASDAQ:RVLP) ownership, while private companies account for 24%February 23, 2023 | finance.yahoo.comRVLP: Year Closes on a Strong NoteFebruary 3, 2023 | finance.yahoo.com Get RVL Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for RVLP and its competitors with MarketBeat's FREE daily newsletter. Email Address Strange: Why is Amazon suddenly yielding 39.70%? (Ad)Something big is happening with Amazon stock… While most investors collect ZERO dividends from Amazon… A small group just discovered a "backdoor" way to collect yields up to 39.70%! Click here to see this breakthrough before everyone else → RVLP Media Mentions By Week RVLP Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. RVLP News Sentiment▼0.000.56▲Average Medical News Sentiment RVLP News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. RVLP Articles This Week▼00▲RVLP Articles Average Week Get RVL Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for RVLP and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies CLVR News Today LVTX News Today MYNZ News Today PHVS News Today PROC News Today TXMD News Today SYRS News Today CUE News Today IDYA News Today XENE News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:RVLP) was last updated on 11/17/2024 by MarketBeat.com Staff From Our PartnersBill Gates’s Next Big AI Bet: StargateIn February 2016… when almost nobody was talking about artificial intelligence…. I picked Nvidia as one of ...Brownstone Research | SponsoredThe Crypto That’s Making Wall Street SweatThe Crypto Wall Street Is Desperate to Hide It's happening now, right under everyone's radar. Big tech gian...Crypto 101 Media | SponsoredThere is a little known company that is changing warfareWith geo - political instability around the world investors are flocking to defense contract stocks. There...Reticulate | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | SponsoredThe pin that pops the AI bubbleMy new documentary explores the background to this pattern and how and why I believe it will almost certainly ...Porter & Company | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredTrump Wins… But Elon Says Get Ready to BraceTrump's back in the White House, ready to hit the gas on America's comeback. He's taking on the economy wi...Genesis Gold Group | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding RVL Pharmaceuticals plc Please log in to your account or sign up in order to add this asset to your watchlist. Share RVL Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.